FDA Grants FzioMed Petition for Dispute Resolution Panel Review

A A
San Luis Obispo, Calif.-based FzioMed said the FDA has agreed to hear its appeal on a decision not to approve the company’s Oxiplex Gel spinal product, a clear, absorbable gel applied during lumbar spine surgery.

To View This Article:

Login

Buy This Article Now

Add this article to your cart for $25.00